The objective of this study was to estimate the cost-effectiveness of complying with HCC screening guidelines. For this aim, the authors conduct a Markov model comparing surveillance of patients with cirrhosis as recommended by the guidelines (“gold-standard monitoring”) to “real-life monitoring” from the health care system perspective. The transition probabilities were derived mainly from two French cohorts, CIRVIR and CHANGH.
(Cadier B et al. – Journal of Hepatology, 8 February 2017)